CRNX - Crinetics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending2018-12-312017-12-312016-12-31
Current Assets
Cash And Cash Equivalents44,97314,19212,152
Short Term Investments118,902--
Net Receivables1,58473472
Inventory---
Other Current Assets-239141
Total Current Assets166,68315,16512,365
Long Term Investments---
Property Plant and Equipment4,232400224
Goodwill---
Intangible Assets---
Accumulated Amortization---
Other Assets5003310
Deferred Long Term Asset Charges---
Total Assets171,41515,59812,599
Current Liabilities
Accounts Payable1,456403340
Short/Current Long Term Debt--49
Other Current Liabilities381--
Total Current Liabilities7,925897890
Long Term Debt--163
Other Liabilities3,2652310
Deferred Long Term Liability Charges---
Minority Interest---
Negative Goodwill---
Total Liabilities11,1909201,063
Stockholders' Equity
Misc. Stocks Options Warrants---
Redeemable Preferred Stock---
Preferred Stock---
Common Stock2414
Retained Earnings-43,380-16,265-7,108
Treasury Stock61--
Capital Surplus203,5201,242900
Other Stockholder Equity61--
Total Stockholder Equity160,225-15,022-6,204
Net Tangible Assets160,225-15,022-6,204